Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| HTCO | High-Trend International Group | $53.46 | $42.21 | 375.20% | 11.2M | $83M | $4.55$61.75 |
| EDSA | Edesa Biotech | $11.45 | $4.19 | 57.76% | 7M | $61M | $0.72$11.80 |
| SGMT | Sagimet Biosciences | $8.15 | $2.29 | 38.99% | 46.9M | $191M | $3.03$11.41 |
| MANE | Veradermics | $91.41 | $23.57 | 34.74% | 2.7M | $2.5B | $17.00$101.81 |
| SPRC | SciSparc | $8.71 | $2.02 | 30.19% | 157.4K | $3.8M | $2.98$94.50 |
| CRMU | Themes ETF Trust - Leverage Shares 2x Long Crml Daily ETF | $12.51 | $2.76 | 28.31% | 342.3K | - | $3.99$15.25 |
| QNTM | Quantum BioPharma Ltd. | $4.57 | $0.96 | 26.59% | 1.7M | $21M | $2.07$38.25 |
| ABSI | Absci | $4.80 | $0.86 | 21.83% | 533.9K | $603M | $2.24$5.23 |
| RMAX | RE/MAX Holdings | $9.69 | $1.70 | 21.28% | 12.7M | $161M | $5.46$10.32 |
| QUIK | QuickLogic | $15.55 | $2.47 | 18.88% | 2M | $232M | $4.80$16.89 |
| EUDA | Euda Health | $12.58 | $1.96 | 18.46% | 357.9K | $27M | $5.26$86.00 |
| ONEG | OneConstruction Group | $6.85 | $1.03 | 17.70% | 357.5K | $93M | $0.96$13.50 |
| CRML | Critical Metals | $13.53 | $2.02 | 17.55% | 1.1M | $1.4B | $1.29$32.15 |
| ATXG | Addentax Group | $5.63 | $0.84 | 17.54% | 59.8K | $3.7M | $3.32$27.90 |
| OGN | Organon & Co. | $13.18 | $1.92 | 17.01% | 113.7M | $2.9B | $5.69$13.25 |
| UECG | Themes ETF Trust - Leverage Shares 2x Long Uec Daily ETF | $10.51 | $1.50 | 16.66% | 48.4K | - | $6.75$15.46 |
| LACG | Themes ETF Trust - Leverage Shares 2x Long Lac Daily ETF | $11.09 | $1.53 | 15.95% | 11.5K | - | $6.34$26.22 |
| RVI | Robinhood Ventures Fund I | $35.28 | $4.78 | 15.66% | 8.6K | $385M | $21.00$36.06 |
| CLIK | Click | $3.16 | $0.41 | 14.73% | 169.9K | $9.0M | $1.32$34.20 |
| TRAK | ReposiTrak | $9.31 | $1.19 | 14.59% | 546.2K | $148M | $6.94$23.72 |
| WATT | Energous | $32.27 | $4.08 | 14.47% | 601.9K | $155M | $3.62$32.63 |
| MRDN | Golden Matrix Group | $7.37 | $0.89 | 13.73% | 30.4K | $82M | $5.80$24.42 |
| YDDL | One And One Green Technologies. | $5.25 | $0.63 | 13.64% | 196.5K | $249M | $3.61$16.23 |
| GOAI | Eva Live | $4.01 | $0.44 | 12.32% | 62K | $112M | $1.32$18.00 |
| GNLN | Greenlane | $4.40 | $0.39 | 9.73% | 74.4K | $2.5M | $2.09$101.40 |
Related Articles
Featured Article
This Rare Earth Stock Just Took Control of a Massive Greenland Deposit. Is It a Buy?
Courtney Carlsen|Apr 24, 2026
Critical Metals gained control over a resource-rich project in Greenland, as Western nations look to diversify away from China.
Is Critical Metals Stock a Buy Now?
Courtney Carlsen|Mar 19, 2026
Rare-earth elements are essential for defense and modern technology, and Critical Metals could play a key role in securing these vital minerals.
Why Did Critical Metals Stock Soar 90% Last Month?
Howard Smith|Feb 3, 2026
The development stage mining company provided updates in January that generated excitement among investors.
Why Rare-Earth Stock Critical Metals Soared 108% in October
Neha Chamaria|Nov 10, 2025
Watch this rare-earth stock closely.
Is the White House About to Invest in These Lithium and Rare Earth Miners?
Matthew Benjamin|Oct 12, 2025
The U.S. government may be eyeing investments in mining companies, sending their shares higher.
Is This Healthcare Stock's 10% Yield a Steal of a Deal or Too Good to Be True?
David Jagielski, CPA|Nov 21, 2023
High-yielding stocks may be tantalizing, but they often come with risks.
Need an Extra $4,000 in Dividends Each Year? Invest $68,000 in These 3 Stocks.
David Jagielski, CPA|Jul 21, 2023
These stocks can significantly bolster your income.
Want $5,000 in Annual Dividend Income? Invest in These 3 Stocks
David Jagielski, CPA|Jun 29, 2023
These stocks are down more than 5% this year, and now may be a good time to add them to your portfolio.
3 of the Best Value Stocks to Buy Heading Into April
David Jagielski, CPA|Mar 30, 2022
With these shares at modest valuations, you can score some cheap long-term investments.
Should Investors Hold Out Hope for bluebird bio and Merck Spinoff Organon?
Keith Speights and Brian Orelli, PhD|Jul 10, 2021
Neither healthcare stock has performed well so far this year.
